Company intelligence / Profile preview

Blackbox

Flower Mound, Texas, United Statesblackbox.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Blackbox Bio has developed and commercialized the "Blackbox One," an automated high-throughput rodent behavioral phenotyping platform. The technology enables objective, high-resolution analysis of voluntary rodent behaviors for in vivo neuroscience discovery and preclinical drug development. Their approach allows sensitive detection of investigational interventions' effects on the mammalian nervous system, with published validation in peer-reviewed journals demonstrating its utility for pain research and analgesic differentiation[8].

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (behavioral phenotyping platform)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Blackbox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blackbox.

Explore the full profile